Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.

Singh PK, Deorukhkar AA, Venkatesulu BP, Li X, Tailor R, Bomalaski JS, Krishnan S.

Mol Cancer Ther. 2019 Dec;18(12):2381-2393. doi: 10.1158/1535-7163.MCT-18-0708. Epub 2019 Aug 8.

PMID:
31395686
2.

Hypoxia-targeted gold nanorods for cancer photothermal therapy.

Chen Y, Bian X, Aliru M, Deorukhkar AA, Ekpenyong O, Liang S, John J, Ma J, Gao X, Schwartz J, Singh P, Ye Y, Krishnan S, Xie H.

Oncotarget. 2018 May 29;9(41):26556-26571. doi: 10.18632/oncotarget.25492. eCollection 2018 May 29.

3.

Development and validation of a sensitive LC/MS/MS method for the determination of γ-tocotrienol in rat plasma: application to pharmacokinetic studies.

Liang S, Bian X, Ma J, Arogunjo M, Deorukhkar AA, Krishnan S, Xie H.

Biomed Chromatogr. 2013 Jan;27(1):58-66. doi: 10.1002/bmc.2748. Epub 2012 Apr 20.

4.

Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy.

Xie H, Diagaradjane P, Deorukhkar AA, Goins B, Bao A, Phillips WT, Wang Z, Schwartz J, Krishnan S.

Int J Nanomedicine. 2011;6:259-69. doi: 10.2147/IJN.S15479. Epub 2011 Jan 27.

5.

Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.

Deorukhkar AA, Chander R, Ghosh SB, Sainis KB.

Res Microbiol. 2007 Jun;158(5):399-404. Epub 2007 Mar 20.

PMID:
17467243
6.

A novel N-alkylated prodigiosin analogue induced death in tumour cell through apoptosis or necrosis depending upon the cell type.

Deorukhkar AA, Chander R, Pandey R, Sainis KB.

Cancer Chemother Pharmacol. 2008 Mar;61(3):355-63. Epub 2007 Apr 12.

PMID:
17429627

Supplemental Content

Loading ...
Support Center